Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CBS Corporation (CBS), AMC Networks Inc (AMCX): The World’s Most Popular Serial Killer Says Goodbye

Showtime and corporate parent CBS Corporation (NYSE:CBS) have some bloody shoes to fill with ratings winner Dexter, which recently entered its eighth and final season. The cast and producers said goodbye to fans last week at San Diego Comic-Con.

Michael C. Hall as serial killer Dexter Morgan. Source: ET Online, Showtime.

Dexter stars actor Michael C. Hall as a Miami crime-scene analyst who doubles as a serial killer of crooks. The show’s fan base has grown to the point where Season 8’s June premiere drew 3.2 million viewers, a new record and up 5% over the Season 7 premiere.

Media mavens will rightly point out that Dexter isn’t much of a mainstream winner when compared with The Walking Dead, which has helped AMC Networks Inc (NASDAQ:AMCX) achieve better-than 15% revenue growth in three of the past six quarters.

Meanwhile, Game of Thrones has proved to be so popular — drawing as many as 13 million viewers across all channels — that a surprising number of readers said they would pay a premium if HBO parent Time Warner Inc (NYSE:TWX) would release current-season episodes direct to iTunes for purchase.

Dexter doesn’t draw as well as these shows when it comes to viewership numbers. But a winner is still a winner, and Showtime has a long history of developing niche shows that last. Nurse Jackie, starring Edie Falco, has already completed five seasons. Californication, starring David Duchovny, will air its seventh season next year.

Showtime, like HBO, needs these sorts of fan-supported franchises. Shows like Dexter, which enjoyed a standing ovation from the thousands attending the show’s final main hall panel at Comic-Con. Ray Donovan is the network’s latest try, and it’s working so far.

Starring Liev Schreiber as a Boston-born fixer for Hollywood’s elite, Ray Donovan drew 1.35 million viewers for its opening episode, the best-ever bow for a new Showtime program and 25% better than Homeland‘s 2011 debut, the network said in a press release.

Liev Schreiber as Showtime’s fixer, Ray Donovan. Sources: The Hollywood Reporter and Showtime.

A second episode did even better, drawing 15% more viewers. Executives have since ordered another season. The message? While HBO and Netflix, Inc. (NASDAQ:NFLX) battle for pay-TV supremacy at about 30 million U.S. subscribers each, Showtime’s original programming is drawing growth even as its popular psychopath, Dexter, packs up the kill room. Rarely has CBS Corporation (NYSE:CBS) looked so interesting.

The article The World’s Most Popular Serial Killer Says Goodbye originally appeared on is written by Tim Beyers.

Fool contributor Tim Beyers is a member of the Motley Fool Rule Breakers stock-picking team and the Motley Fool Supernova Odyssey I mission. He owned shares of Netflix and Time Warner at the time of publication. He was also long Jan. 2014 Netflix $50 call options. Check out Tim’s Web home and portfolio holdings, or connect with him on Google+Tumblr, or Twitter, where he goes by @milehighfool. You can also get his insights delivered directly to your RSS reader.The Motley Fool recommends AMC Networks and Netflix and owns shares of Netflix.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.